Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
After finishing at $21.3 in the prior trading day, Enliven Therapeutics Inc (NASDAQ: ELVN) closed at $20.29, down -4.74%%. In other words, the price has decreased by -$4.74% from its previous closing price. On the day, 0.62 million shares were traded.
Ratios:
Our goal is to gain a better understanding of ELVN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 21.06 and its Current Ratio is at 21.06. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on June 16, 2025, initiated with a Buy rating and assigned the stock a target price of $37.
On December 13, 2024, BTIG Research started tracking the stock assigning a Buy rating and target price of $42.
On September 09, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $37.H.C. Wainwright initiated its Buy rating on September 09, 2024, with a $37 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 20 ’25 when Lyssikatos Joseph P bought 12,500 shares for $21.57 per share.
Kintz Samuel sold 12,500 shares of ELVN for $277,292 on Jun 17 ’25. The PRESIDENT AND CEO now owns 952,892 shares after completing the transaction at $22.18 per share. On Jun 13 ’25, another insider, Hohl Benjamin, who serves as the CHIEF FINANCIAL OFFICER of the company, sold 3,000 shares for $22.55 each. As a result, the insider received 67,655 and left with 23,000 shares of the company.
Stock Price History:
Over the past 52 weeks, ELVN has reached a high of $30.03, while it has fallen to a 52-week low of $13.30. The 50-Day Moving Average of the stock is 7.79%, while the 200-Day Moving Average is calculated to be -8.93%.
Shares Statistics:
A total of 49.04M shares are outstanding, with a floating share count of 38.76M. Insiders hold about 34.29% of the company’s shares, while institutions hold 61.32% stake in the company.
